Aspirin and Primary Cancer Risk Reduction in Ischemic Cardiac or Cerebrovascular Disease Survivors: A Nationwide Population-Based Propensity-Matched Cohort Study

SIMPLE SUMMARY: Long-term low-dose aspirin use was associated with a reduced risk of primary cancer in survivors of ischemic cardiac or cerebrovascular disease. Thus, in contrast to the situation for the general population (for which the anticancer effects of aspirin are still controversial), long-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yen-Hsiang, Hsu, Ren-Jun, Wang, Tzu-Hwei, Wu, Chen-Ta, Huang, Sheng-Yao, Hsu, Chung-Y., Hsu, Wen-Lin, Liu, Dai-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817941/
https://www.ncbi.nlm.nih.gov/pubmed/36612095
http://dx.doi.org/10.3390/cancers15010097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817941/
https://www.ncbi.nlm.nih.gov/pubmed/36612095
http://dx.doi.org/10.3390/cancers15010097

Ejemplares similares